Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof

Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof

US Patent 11319358 · Granted May 3, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Chimeric antigen receptor T regulatory cells for the treatment of atherosclerosi2025
Switch costimulatory receptors2025
Compositions and methods for generating a persisting population of T cells usefu2025
CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric a2025
CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric a2025
Altering gene expression in cart cells and uses thereof2025
Use of trans-signaling approach in chimeric antigen receptors2025
Methods for improving the efficacy and expansion of immune cells2025
Use of the CD2 signaling domain in second-generation chimeric antigen receptors2025
Use of CD2/5/7 knock-out anti-CD2/5/7 chimeric antigen receptor T cells against 2025
Use of CD2/5/7 knock-out anti-CD2/5/7 chimeric antigen receptor T cells against 2025
Treatment of cancer using humanized anti-BCMA chimeric antigen receptor2025